Literature DB >> 9055015

An HIV-1 infected long-term non-progressor (LTNP): molecular analysis of HIV-1 strains in the vpr and nef genes.

N K Saksena1, Y C Ge, B Wang, S H Xiang, D E Dwyer, C Randle, P Palasanthiran, J Ziegler, A L Cunningham.   

Abstract

We describe a long-term non-progressive injecting drug user (IDU) who was infected with human immunodeficiency virus type-1 (HIV-1) in 1984, and has survived with stable CD4+ T-cell counts (> 800/microliters blood) without any acquired immune deficiency syndrome (AIDS) related illness. With a goal to investigate the molecular nature of HIV-1 strains infecting this patient, we amplified the nef and vpr genes directly from the fresh uncultured peripheral blood mononuclear cells (PBMCs), and carried out co-culture studies. Sequence analysis of the nef gene (from 1994 samples) showed no deletions (as has been previously reported) expected for a 7 base pair duplication at the C-terminus which prematurely terminated the nef reading frame, whereas even after repeated attempts the nef gene could not be amplified from the 1992 PBMC samples. In contrast, the vpr gene (from 1992 and 1994 samples) revealed two distinct quasispecies with no apparent defects. We observed five amino acid substitutions, between residues 83-90, at the C-terminus which has been recently implicated in G2 cell cycle arrest as an early step to HIV-1 infection. In the light of recent evidence on the role of nef gene defects/attenuations in long-term survival of HIV-1 infected patients, it may be that the nef gene defect created by gene duplication, which eliminated the cysteine-206 crucial in disulfide bond formation, may play a role in chronic HIV-1 infection in this patient. These data further suggest that deletions in the nef gene may not be the only reason for long-term non-progression of HIV-1 infection in some individuals, but the gene defects like duplication and subtle mutations in the functional motifs of both nef and vpr genes may confer similar protection in HIV-1 infected patients surviving for longer periods of time with stable CD4 counts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9055015

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  9 in total

1.  SIV Vpr evolution is inversely related to disease progression in a morphine-dependent rhesus macaque model of AIDS.

Authors:  Richard J Noel; Anil Kumar
Journal:  Virology       Date:  2006-10-24       Impact factor: 3.616

2.  Immunogenicity of a lentiviral-based DNA vaccine driven by the 5'LTR of the naturally attenuated caprine arthritis encephalitis virus (CAEV) in mice and macaques.

Authors:  Géraldine Arrode-Brusés; Ramakrishna Hegde; Yuhuai Jin; Zhengian Liu; Opendra Narayan; Yahia Chebloune
Journal:  Vaccine       Date:  2012-03-02       Impact factor: 3.641

3.  RNA trafficking signals in human immunodeficiency virus type 1.

Authors:  A J Mouland; H Xu; H Cui; W Krueger; T P Munro; M Prasol; J Mercier; D Rekosh; R Smith; E Barbarese; E A Cohen; J H Carson
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

4.  Entire genome of a strain of human immunodeficiency virus type 1 with a deletion of nef that was recovered 20 years after primary infection: large pool of proviruses with deletions of env.

Authors:  Graziella Calugi; Francesco Montella; Cartesio Favalli; Arrigo Benedetto
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

Review 5.  Morphine and rapid disease progression in nonhuman primate model of AIDS: inverse correlation between disease progression and virus evolution.

Authors:  Vanessa Rivera-Amill; Peter S Silverstein; Richard J Noel; Santosh Kumar; Anil Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-16       Impact factor: 4.147

6.  Maintenance of an intact human immunodeficiency virus type 1 vpr gene following mother-to-infant transmission.

Authors:  V R Yedavalli; C Chappey; N Ahmad
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 Vpr polymorphisms associated with progressor and nonprogressor individuals alter Vpr-associated functions.

Authors:  Kevin Hadi; Leah A Walker; Debjani Guha; Ramachandran Murali; Simon C Watkins; Patrick Tarwater; Alagarsamy Srinivasan; Velpandi Ayyavoo
Journal:  J Gen Virol       Date:  2013-12-03       Impact factor: 3.891

8.  Long-term central and effector SHIV-specific memory T cell responses elicited after a single immunization with a novel lentivector DNA vaccine.

Authors:  Géraldine Arrode-Brusés; Maha Moussa; Monique Baccard-Longere; François Villinger; Yahia Chebloune
Journal:  PLoS One       Date:  2014-10-22       Impact factor: 3.240

9.  Immune escape mutations in HIV-1 controllers in the Brazilian Amazon region.

Authors:  Samara Tatielle Monteiro Gomes; Ednelza da Silva Graça Amoras; Érica Ribeiro Gomes; Maria Alice Freitas Queiroz; Edivaldo Costa Sousa Júnior; Janaína Mota de Vasconcelos Massafra; Poliana da Silva Lemos; João Lídio Vianez Júnior; Ricardo Ishak; Antonio Carlos Rosário Vallinoto
Journal:  BMC Infect Dis       Date:  2020-07-25       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.